As of 2025-07-04, the EV/EBITDA ratio of Orgenesis Inc (ORGS) is -0.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ORGS's latest enterprise value is 23.51 mil USD. ORGS's TTM EBITDA according to its financial statements is -28.39 mil USD. Dividing these 2 quantities gives us the above ORGS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.1x | 12.8x |
| Forward P/E multiples | 17.1x - 32.0x | 20.6x |
| Fair Price | (123.94) - (95.85) | (120.99) |
| Upside | -5974.1% - -4642.6% | -5834.3% |
| Date | EV/EBITDA |
| 2025-04-21 | -0.88 |
| 2025-04-17 | -0.84 |
| 2025-04-16 | -0.89 |
| 2025-04-15 | -0.89 |
| 2025-04-14 | -0.88 |
| 2025-04-11 | -0.81 |
| 2025-04-10 | -0.79 |
| 2025-04-09 | -0.81 |
| 2025-04-08 | -0.83 |
| 2025-04-07 | -0.84 |
| 2025-04-04 | -0.89 |
| 2025-04-03 | -0.89 |
| 2025-04-02 | -0.88 |
| 2025-04-01 | -0.87 |
| 2025-03-31 | -0.88 |
| 2025-03-28 | -1.01 |
| 2025-03-27 | -1.02 |
| 2025-03-26 | -0.98 |
| 2025-03-25 | -0.91 |
| 2025-03-24 | -0.91 |
| 2025-03-21 | -0.93 |
| 2025-03-20 | -0.90 |
| 2025-03-19 | -0.91 |
| 2025-03-18 | -0.93 |
| 2025-03-17 | -0.98 |
| 2025-03-14 | -1.02 |
| 2025-03-13 | -1.02 |
| 2025-03-12 | -0.98 |
| 2025-03-11 | -0.92 |
| 2025-03-10 | -0.96 |
| 2025-03-07 | -1.11 |
| 2025-03-06 | -1.19 |
| 2025-03-05 | -1.21 |
| 2025-03-04 | -1.13 |
| 2025-03-03 | -1.06 |
| 2025-02-28 | -1.07 |
| 2025-02-27 | -1.24 |
| 2025-02-26 | -1.07 |
| 2025-02-25 | -0.80 |
| 2025-02-24 | -0.87 |
| 2025-02-21 | -0.83 |
| 2025-02-20 | -0.76 |
| 2025-02-19 | -0.76 |
| 2025-02-18 | -0.76 |
| 2025-02-14 | -0.75 |
| 2025-02-13 | -0.72 |
| 2025-02-12 | -0.77 |
| 2025-02-11 | -0.76 |
| 2025-02-10 | -0.72 |
| 2025-02-07 | -0.70 |